NasdaqGM:TMDXMedical Equipment
TransMedics Group (TMDX) Net Margin Jump Reinforces Bullish Profit Quality Narratives
TransMedics Group FY 2025 earnings snapshot
TransMedics Group (TMDX) closed FY 2025 with fourth quarter revenue of US$160.8 million and basic EPS of US$3.08, alongside trailing twelve month revenue of US$605.5 million and EPS of US$5.60 that frame a much larger full year earnings base. Over the past few quarters, the company has seen revenue range from US$143.5 million to US$160.8 million while quarterly EPS moved between US$0.71 and US$3.08. This gives investors a clearer read on how higher...